NUVALENT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.86 USD | +1.20% |
|
+6.53% | -9.15% |
| Apr. 17 | Nuvalent Insider Sold Shares Worth $2,458,335, According to a Recent SEC Filing | MT |
| Apr. 17 | Jefferies Initiates Nuvalent With Buy Rating, $97 Price Target | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 919.3 | 1,681 | 4,609 | 4,312 | - | - |
| Enterprise Value (EV) 1 | 919.3 | 1,681 | 4,609 | 4,312 | 4,312 | 4,312 |
| P/E ratio | -8.94 x | -18 x | -33.9 x | -23 x | -19.8 x | -17.7 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | 540 x | 151 x |
| EV / Revenue | - | - | - | - | 540 x | 151 x |
| EV / EBITDA | -20.1 x | -19.5 x | -30.8 x | -20.9 x | -18.8 x | - |
| EV / FCF | -2.21 x | -22.2 x | -46.2 x | -27.3 x | -24.1 x | -22.5 x |
| FCF Yield | -45.3% | -4.5% | -2.16% | -3.66% | -4.15% | -4.44% |
| Price to Book | 3.23 x | 3.65 x | 6.73 x | 9.82 x | 8.53 x | - |
| Nbr of stocks (in thousands) | 48,284 | 56,441 | 62,630 | 64,491 | - | - |
| Reference price 2 | 19.04 | 29.78 | 73.59 | 66.86 | 66.86 | 66.86 |
| Announcement Date | 3/29/22 | 3/16/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | 7.98 | 28.58 |
| EBITDA 1 | - | -45.82 | -86.11 | -149.5 | -206.7 | -229.6 | - |
| EBIT 1 | - | -45.82 | -86.11 | -149.5 | -201 | -230.2 | -260.1 |
| Operating Margin | - | - | - | - | - | -2,884.24% | -910.23% |
| Earnings before Tax (EBT) 1 | - | -46.34 | -81.85 | -126.2 | -176.4 | -214 | -233.2 |
| Net income 1 | -14.56 | -46.34 | -81.85 | -126.2 | -184.5 | -219.9 | -255.9 |
| Net margin | - | - | - | - | - | -2,755.7% | -895.58% |
| EPS 2 | -0.9400 | -2.130 | -1.650 | -2.170 | -2.911 | -3.372 | -3.779 |
| Free Cash Flow 1 | - | -416.4 | -75.64 | -99.74 | -158 | -179 | -191.5 |
| FCF margin | - | - | - | - | - | -2,243.11% | -670.08% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 5/28/21 | 3/29/22 | 3/16/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA 1 | -12.43 | -17.38 | -17.69 | -18.73 | -20.39 | -29.3 | -30.21 | -34.06 | -38.78 | -46.44 | -48 | -51 | -53 | -55 | - |
| EBIT 1 | -12.43 | -17.38 | -17.69 | -18.73 | -20.39 | -29.3 | -30.21 | -34.06 | -38.78 | -46.44 | -46.61 | -48.87 | -51.01 | -53.25 | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -12.43 | -17.29 | -17.55 | -18.47 | -19.72 | -26.12 | -25.19 | -29.09 | -33.64 | -38.29 | -40.96 | -43.02 | -45.22 | -47.26 | - |
| Net income 1 | -12.43 | -17.29 | -17.55 | -18.47 | -19.72 | -26.12 | -25.19 | -29.09 | -33.64 | -38.29 | -42.45 | -44.64 | -46.95 | -49.27 | - |
| Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS 2 | -0.3900 | -0.3600 | -0.3600 | -0.3800 | -0.4100 | -0.4900 | -0.4400 | -0.5100 | -0.5900 | -0.6200 | -0.6701 | -0.7042 | -0.7465 | -0.7879 | -0.7450 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/10/21 | 3/29/22 | 5/12/22 | 8/10/22 | 11/10/22 | 3/16/23 | 5/11/23 | 8/10/23 | 11/14/23 | 2/27/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -416 | -75.6 | -99.7 | -158 | -179 | -192 |
| ROE (net income / shareholders' equity) | - | -36.5% | -21.9% | -21.7% | -30.9% | -41.7% | - |
| ROA (Net income/ Total Assets) | - | -30.4% | -21.1% | -20.8% | -29.3% | -39% | - |
| Assets 1 | - | 152.2 | 388.1 | 607.4 | 630.4 | 564.2 | - |
| Book Value Per Share 2 | - | 5.900 | 8.170 | 10.90 | 6.810 | 7.840 | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - |
| Announcement Date | 5/28/21 | 3/29/22 | 3/16/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
66.86
USD
Average target price
101.1
USD
Spread / Average Target
+51.23%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.15% | 4.28B | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- NUVL Stock
- Financials Nuvalent, Inc.
